FindMyKOL

Bryan Sauer, MD

Basic profile

University of Virginia

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionCharlottesville, VA · SoutheastSpecialtyGastroenterologyFocusGastroenterology
Active KOLFindMyKOL type: NationalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Bryan Sauer is a Gastroenterology physician affiliated with University of Virginia. OpenAlex indexes 192 publications with 8,070 citations (h-index 36). By OpenAlex citation count, this profile ranks in the top 10% of Gastroenterology profiles in the FindMyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
192publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

8,070citations

Citations across these publications.

36h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • GENZYME CORPORATION
    Program year202541 payments
    $114,235
  • Regeneron Healthcare Solutions, Inc.
    Program year202548 payments
    $106,430
  • Takeda Pharmaceuticals U.S.A., Inc.
    Program year20258 payments
    $4,147
All 11 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    80.1%
    Proton pump inhibitor62%
    Omeprazole65%Pantoprazole Sodium29%Dexlansoprazole Dr6%
    Part D<11 patients
    Osmotic Laxative14.4%
    Gavilyte-G100%
    Part D≥39 patients

    + 1 more class in this area

  • Respiratory

    11.6%
    Corticosteroid11.6%
    Flovent Hfa100%
    Part D<11 patients
  • Dermatology

    8.2%
    Interleukin-4 Receptor alpha Antagonist8.2%
    Dupixent Syringe54%Dupixent Pen46%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”